LLY vs META: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
Eli Lilly and Company · Healthcare
$1,179.09
+31.7% upside to fair value
High Conviction
Grade A
High Quality
VS
Meta Platforms, Inc. · Communication Services
$646.01
+43.0% upside to fair value
High Conviction
Grade A
High Quality
QuantHub Verdict
META has more upside to fair value
(+43.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
META |
| Current Price |
$1,179.09 |
$646.01 |
| Fair Value Estimate |
$1,552.32 |
$924.09 |
| Upside to Fair Value |
+31.7%
|
+43.0%
|
| Market Cap |
$1,110.4B |
$1,639.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
34.3x
|
15.0x
|
| Price / Sales |
14.6x
|
7.6x
|
| Price / FCF |
77.7x
|
33.9x
|
| Revenue Growth YoY |
+55.5%
|
+33.1%
|
| Gross Margin |
83.5%
|
81.9%
|
| Operating Margin |
45.9%
|
41.2%
|
| Return on Equity |
101.3%
|
33.2%
|
| Dividend Yield |
0.55% |
0.33% |
| FCF Yield |
1.29%
|
2.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Eli Lilly is a global biopharma company whose exceptionally profitable cardiometabolic franchises, led by Mounjaro and Zepbound, are driving a high-quality growth phase: revenue rose 55.5% year over year and earnings rose 168.0% year over year in the most recent quarter, while gross, operating, and net margins were 83.5%, 45.9%, and 35.0%, respectively. Business quality is high because tirzepatid…
Meta Platforms operates the Facebook, Instagram, Messenger and WhatsApp ecosystem and monetizes its 3.56 billion Family daily active people primarily through digital advertising. Business quality is high: the core platform combines global network effects, advertiser measurement data, creator supply, cross-app distribution and AI-driven ad ranking, supporting 81.9% gross margin, 41.2% operating ma…
Accumulation Zones
| Metric |
LLY |
META |
| Zone Low |
$1,164.24 |
$693.07 |
| Zone High |
$1,319.47 |
$785.48 |
| In Buy Zone? |
Yes
|
Yes
|